ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Buy
Hold
Sell

We haven’t received any recent analyst ratings for ADVM.

Analyst & Firm Rating Price Target Upside
Downside
Date
HC Wainwright & Co
HC Wainwright & Co
Matthew Caufield
67% 1-yr ADVM win rate
17 Nov ‘25 24 days ago
RBC Capital
RBC Capital
Lisa Walter
28 Oct ‘25 1 month ago